Bellevue F.(L)-B.Obesity Sol.B USD/ LU0415392322 /
| NAV2024-04-19 | Chg.+0.9100 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 492.3800USD | +0.19% | reinvestment | Equity Worldwide | Waystone M.Co.(Lux) ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2009 | - | - | - | 2.88 | 4.05 | 5.17 | 7.56 | 0.15 | 5.07 | -10.89 | 6.76 | 0.37 | - |
| 2010 | 1.37 | 2.88 | 4.90 | -1.65 | -12.38 | -3.44 | 3.02 | -2.03 | 12.01 | 6.40 | -4.72 | 7.46 | +12.10% |
| 2011 | -2.91 | 0.16 | 0.92 | 8.13 | 0.01 | -0.79 | -2.10 | -13.30 | -7.02 | 5.96 | 0.39 | 2.95 | -9.00% |
| 2012 | 13.39 | 1.68 | 3.30 | 0.35 | -0.58 | 3.74 | 3.80 | 1.95 | 5.67 | -8.59 | 4.96 | -0.58 | +31.48% |
| 2013 | 7.49 | 1.65 | 7.76 | 9.32 | 2.92 | -3.92 | 14.70 | -2.77 | 9.09 | -3.21 | 8.20 | 0.98 | +63.75% |
| 2014 | 9.96 | 6.60 | -10.90 | -4.05 | 2.82 | 8.50 | -1.15 | 11.32 | -1.20 | 10.11 | 2.59 | -0.70 | +36.33% |
| 2015 | 7.89 | 5.71 | 0.50 | -3.89 | 9.81 | -0.41 | 2.01 | -11.59 | -12.36 | 9.46 | 2.34 | 0.90 | +7.63% |
| 2016 | -23.11 | -5.21 | 4.49 | 3.99 | 3.33 | -9.40 | 13.18 | -2.83 | 2.91 | -14.05 | 8.71 | -3.95 | -24.69% |
| 2017 | 7.45 | 7.20 | -0.52 | 1.70 | -3.85 | 7.46 | 2.75 | 4.61 | -0.96 | -5.90 | 1.16 | 0.93 | +23.13% |
| 2018 | 7.78 | -5.60 | -0.62 | -5.37 | 3.97 | 0.07 | 6.10 | 4.98 | -1.32 | -16.40 | 3.90 | -10.74 | -15.17% |
| 2019 | 13.03 | 4.24 | 0.92 | -6.72 | -4.33 | 9.18 | -1.55 | -3.17 | -3.54 | 6.53 | 11.31 | 1.23 | +27.86% |
| 2020 | -5.53 | -2.11 | -8.03 | 14.76 | 9.99 | 3.75 | -1.33 | 1.06 | -0.51 | -4.12 | 11.83 | 3.83 | +23.01% |
| 2021 | 4.40 | -2.44 | -5.57 | 4.10 | 0.64 | 5.30 | 3.02 | 2.02 | -5.79 | -0.24 | -4.02 | 0.28 | +0.86% |
| 2022 | -12.24 | -3.09 | 5.11 | -8.24 | -2.64 | 1.80 | 3.65 | -2.41 | -1.68 | 6.69 | 6.19 | -4.06 | -12.12% |
| 2023 | 2.10 | -6.74 | 1.08 | 1.96 | -2.08 | -0.59 | 0.30 | -1.16 | -4.07 | -6.94 | 3.61 | 2.17 | -10.52% |
| 2024 | 2.45 | 3.29 | 2.48 | -5.62 | - | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 9.70% | 12.51% | 12.94% | 19.28% | 22.28% |
| Sharpe ratio | 0.44 | 0.33 | -0.93 | -0.52 | -0.05 |
| Best month | +3.29% | +3.61% | +3.61% | +6.69% | +14.76% |
| Worst month | -5.62% | -6.94% | -6.94% | -12.24% | -12.24% |
| Maximum loss | -5.79% | -5.79% | -16.73% | -35.26% | -35.26% |
| Outperformance | +9.64% | - | +7.97% | +0.11% | -13.32% |
All quotes in USD
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Bellevue F.(L)-B.Obesity Sol.I2 ... | reinvestment | 161.1400 | -4.82% | -4.44% | |
| Bellevue F.(L)-B.Obesity Sol.I U... | reinvestment | 549.1100 | -7.45% | -15.53% | |
| Bellevue F.(L)-B.Obesity Sol.I E... | reinvestment | 689.2500 | -4.95% | -4.85% | |
| Bellevue F.(L)-B.Obesity Sol.I C... | reinvestment | 440.1300 | -6.33% | -16.09% | |
| Bellevue F.(L)-B.Obesity Sol.I G... | reinvestment | 466.7100 | -7.33% | -4.98% | |
| Bellevue F.(L)-B.Obesity Sol.B U... | reinvestment | 492.3800 | -8.10% | -17.29% | |
| Bellevue F.(L)-B.Obesity Sol.B C... | reinvestment | 392.5400 | -6.98% | -17.84% | |
| Bellevue F.(L)-B.Obesity Sol.B E... | reinvestment | 615.7600 | -5.61% | -6.83% |
Performance
| YTD | +2.35% | ||
|---|---|---|---|
| 6 Months | +3.91% | ||
| 1 Year | -8.10% | ||
| 3 Years | -17.29% | ||
| 5 Years | +14.30% | ||
| Since start | +293.90% | ||
| Year | |||
| 2023 | -10.52% | ||
| 2022 | -12.12% | ||
| 2021 | +0.86% | ||
| 2020 | +23.01% | ||
| 2019 | +27.86% | ||
| 2018 | -15.17% | ||
| 2017 | +23.13% | ||
| 2016 | -24.69% | ||
| 2015 | +7.63% | ||
